BMC BiologyGeneticsPeer-reviewed journal article
Dysregulation of innate immune signaling in animal models of Spinal Muscular Atrophy
Eric L. GarciaiD, Rebecca E. SteineriD, Amanda C. Raimer, Laura E. HerringiD, A. Gregory MateraiD, Ashlyn M. Spring
Abstract
BackgroundSpinal Muscular Atrophy (SMA) is a devastating neuromuscular disease caused by hypomorphic loss of function in the Survival Motor Neuron (SMN) protein. SMA presents across broad spectrum of disease severity. Unfortunately, vertebrate models of intermediate SMA have been difficult to generate and are thus unable to address key aspects of disease etiology. To address these issues, we developed a Drosophila model system that recapitulates the full range of SMA severity, allowing studies of pre-onset biology as well as late-stage disease processes. ResultsHere, we carried out transcriptomic and proteomic profiling of mild and intermediate Drosophila models of SMA to elucidate molecules and pathways that contribute to the disease. Using this approach, we elaborated a role for the SMN complex in the regulation of innate immune signaling. We find that mutation or tissue-specific depletion of SMN induces hyperactivation of the Immune Deficiency (IMD) and Toll pathways, leading to overexpression of antimicrobial peptides (AMPs) and ectopic formation of melanotic masses in the absence of an external challenge. Furthermore, knockdown of downstream targets of these signaling pathways reduced melanotic mass formation caused by SMN loss. Importantly, we identify SMN as a negative regulator of an ubiquitylation complex that includes Traf6, Bendless and Diap2, and plays a pivotal role in several signaling networks. ConclusionsIn alignment with recent research on other neurodegenerative diseases, these findings suggest that hyperactivation of innate immunity contributes to SMA pathology. This work not only provides compelling evidence that hyperactive innate immune signaling is a primary effect of SMN depletion, but it also suggests that the SMN complex plays a regulatory role in this process in vivo. In summary, immune dysfunction in SMA is a consequence of reduced SMN levels and is driven by cellular and molecular mechanisms that are conserved between insects and mammals.
- organism: Drosophila
- assay: proteomics
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
- Citations
- 8
- FWCI
- 2.25
- Field percentile
- top 13%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dysregulation of the Tweak/Fn14 pathway in skeletal muscle of spinal muscular atrophy mice
K. E. Meijboom, E. McFall, … M. Bowerman·Skeletal MusclePeer-reviewed·Dec 1, 2022
- Comprehensive modeling of Spinal Muscular Atrophy in Drosophila melanogaster
Ashlyn M. Spring, Amanda C. Raimer, … A. Gregory Matera·Frontiers in Molecular NeurosciencePeer-reviewed·May 16, 2019
- Genomic stress drives activation of interferon signaling and innate immune pathways during SMA Type II myoblasts differentiation
Sabrina Mazzucchi, Anne Bigot, … Piera Smeriglio·bioRxiv·Dec 25, 2025
- SMN deficiency induces an early non-atrophic myopathy with alterations in the contractile and excitatory coupling machinery of skeletal myofibers in the SMN{triangleup}7 mouse model of spinal muscular atrophy
Maria Teresa Berciano, Alaó Gatius, … Olga Tapia·International Journal of Molecular SciencesPeer-reviewed·Nov 19, 2024
- Hyperactive intestinal proteolysis underlies smn-1 mutant phenotypes
Anusha Iyengar, Lindsey Philips, Adam D. Norris·bioRxiv·Aug 20, 2026
- RNase H1 counteracts DNA damage and ameliorates SMN-dependent phenotypes in a Drosophila model of Spinal Muscular Atrophy
Livia Scatolini, Lucia Graziadio, … Grazia Daniela Raffa·bioRxiv·Apr 17, 2025